Furthermore, overexpression of RORA increased aromatase expression ~10-fold in neuroblastoma cells [40], while treatment with bexarotene, a retinoid X receptor agonist, likewise significantly increased aromatase expression and E2 levels in hippocampal slices [43]. This evidence concerns the gene CYP19A1 and neuroblastoma.